Skip to main content

Table 3 Satisfaction with the BETACONNECT

From: Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study

Question Initial visit Follow-up visit after 4 weeks Follow-up visit after 12 weeks Follow-up visit after 24 weeks
…way of injection before study start …BETACONNECT®   
  N = 93 N = 115 N = 109 N = 99
Satisfaction with…, NAS range 0–10
 Mean (SD) 7.4 (2.0) 8.3 (1.9) 8.5 (1.5) 8.4 (1.5)
 Median (range) 8 (1–10) 9 (1–10) 9 (2–10) 9 (3–10)
  N = 94 N = 114 N = 110 N = 98
Injection related pain with…, NAS range 0–10
 Mean (SD) 4.2 (2.5) 3.6 (2.5) 4.0 (2.6) 4.1 (2.6)
 Median (range) 4 (0–10) 3 (0–10) 4 (0–10) 4 (0–10)
  N = 96 N = 116 N = 111 N = 99
Prophylactic use of analgesics prior to injection with…, % (patients with corresponding questionnaire) 14.6 17.2 17.1 9.1
  1. NAS numerical analogue scale; SD standard deviation